Role of igf-binding protein 3 in the resistance of egfr mutant lung cancer cells to egfr-tyrosine kinase inhibitors

HIGHLIGHTS

• who: Inhibitors and collaborators from the Department of Pulmonary and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea, Asan Institute for Life Sciences, AsanEditor: Giuseppe Viglietto, University Magna Graecia, Italy have published the research: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors, in the Journal: PLOS ONE | www.plosone.org of May/13,/2013
• what: In the present study, IGFBP-3 expression was examined in EGFR mutant lung cancer cells with acquired resistance to EGFR-TKIs, and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.